These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

7263 related items for PubMed ID: 11009083

  • 21. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice.
    Johnson BJ, Costelloe EO, Fitzpatrick DR, Haanen JB, Schumacher TN, Brown LE, Kelso A.
    Proc Natl Acad Sci U S A; 2003 Mar 04; 100(5):2657-62. PubMed ID: 12601154
    [Abstract] [Full Text] [Related]

  • 22. Efficacy of IL-2- versus IL-15-stimulated CD8 T cells in adoptive immunotherapy.
    Mueller K, Schweier O, Pircher H.
    Eur J Immunol; 2008 Oct 04; 38(10):2874-85. PubMed ID: 18825743
    [Abstract] [Full Text] [Related]

  • 23. Identification of an interferon-gamma-inducible carcinoembryonic antigen (CEA) CD8(+) T-cell epitope, which mediates tumor killing in CEA transgenic mice.
    Schmitz J, Reali E, Hodge JW, Patel A, Davis G, Schlom J, Greiner JW.
    Cancer Res; 2002 Sep 01; 62(17):5058-64. PubMed ID: 12208761
    [Abstract] [Full Text] [Related]

  • 24. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ, Brooks AD, Lee JK, Fenton RG, Komschlies KL, Wigginton JM, Winkler-Pickett R, Wiltrout RH.
    J Immunol; 1998 Oct 15; 161(8):3957-65. PubMed ID: 9780164
    [Abstract] [Full Text] [Related]

  • 25. Genetically attenuated parasite vaccines induce contact-dependent CD8+ T cell killing of Plasmodium yoelii liver stage-infected hepatocytes.
    Trimnell A, Takagi A, Gupta M, Richie TL, Kappe SH, Wang R.
    J Immunol; 2009 Nov 01; 183(9):5870-8. PubMed ID: 19812194
    [Abstract] [Full Text] [Related]

  • 26. Role of effector cell-derived IL-4, IL-5, and perforin in early and late stages of type 2 CD8 effector cell-mediated tumor rejection.
    Dobrzanski MJ, Reome JB, Dutton RW.
    J Immunol; 2001 Jul 01; 167(1):424-34. PubMed ID: 11418679
    [Abstract] [Full Text] [Related]

  • 27. Cytokine-deficient CD8+ Tc1 cells induced by IL-4: retained inflammation and perforin and Fas cytotoxicity but compromised long term killing of tumor cells.
    Sad S, Li L, Mosmann TR.
    J Immunol; 1997 Jul 15; 159(2):606-13. PubMed ID: 9218575
    [Abstract] [Full Text] [Related]

  • 28. Tc1 and Tc2 effector cell therapy elicit long-term tumor immunity by contrasting mechanisms that result in complementary endogenous type 1 antitumor responses.
    Dobrzanski MJ, Reome JB, Hollenbaugh JA, Dutton RW.
    J Immunol; 2004 Feb 01; 172(3):1380-90. PubMed ID: 14734713
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Interferon-gamma-dependent phagocytic cells are a critical component of innate immunity against metastatic mammary carcinoma.
    Pulaski BA, Smyth MJ, Ostrand-Rosenberg S.
    Cancer Res; 2002 Aug 01; 62(15):4406-12. PubMed ID: 12154047
    [Abstract] [Full Text] [Related]

  • 34. T cell-mediated, IFN-gamma-facilitated rejection of murine B16 melanomas.
    Böhm W, Thoma S, Leithäuser F, Möller P, Schirmbeck R, Reimann J.
    J Immunol; 1998 Jul 15; 161(2):897-908. PubMed ID: 9670968
    [Abstract] [Full Text] [Related]

  • 35. A critical requirement of interferon gamma-mediated angiostasis for tumor rejection by CD8+ T cells.
    Qin Z, Schwartzkopff J, Pradera F, Kammertoens T, Seliger B, Pircher H, Blankenstein T.
    Cancer Res; 2003 Jul 15; 63(14):4095-100. PubMed ID: 12874012
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Protective immunity from naive CD8+ T cells activated in vitro with MHC class I binding immunogenic peptides and IL-2 in the absence of specialized APCs.
    Hauser C, Zipprich F, Leblond I, Wirth S, Hügin AW.
    J Immunol; 1999 Jul 01; 163(1):330-6. PubMed ID: 10384132
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Trypanosoma cruzi: roles for perforin-dependent and perforin-independent immune mechanisms in acute resistance.
    Nickell SP, Sharma D.
    Exp Parasitol; 2000 Apr 01; 94(4):207-16. PubMed ID: 10831388
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 364.